TRVI · ISSUER CIK 1563880
Trevi Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Trevi Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $596K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$596KInsider selling
−$596KNet open-market
Sep 17, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 202616:55 | Sep 15, 2026 | TRVI | Director | S · Sell10b5-1 | $15.09 | −39,473 | 6,351 | -86% | −$596K | ||
| Sep 17, 202616:55 | Sep 15, 2026 | TRVI | Director | M · Exercise10b5-1 | $3.19 | +39,473 | 27,403 | — | $126K |